177 related articles for article (PubMed ID: 11995707)
1. [Role of irinotecan in the treatment of small cell carcinoma].
Crinò L
Tumori; 2001; 87(6):A35-7. PubMed ID: 11995707
[No Abstract] [Full Text] [Related]
2. [Irinotecan].
Yokoyama A
Nihon Rinsho; 2002 May; 60 Suppl 5():339-42. PubMed ID: 12101684
[No Abstract] [Full Text] [Related]
3. Irinotecan in small-cell lung cancer--Japanese trials.
Fukuoka M; Masuda N; Kudoh S; Negoro S
Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):57-62. PubMed ID: 10981292
[TBL] [Abstract][Full Text] [Related]
4. Irinotecan in the treatment of small cell lung cancer.
Masuda N; Fukuoka M
Expert Rev Anticancer Ther; 2001 Aug; 1(2):187-95. PubMed ID: 12113024
[TBL] [Abstract][Full Text] [Related]
5. Irinotecan therapy for small-cell lung cancer.
Sandler A
Oncology (Williston Park); 2002 Apr; 16(4):419-25, 428, 433; discussion 433-4, 437-8. PubMed ID: 12017533
[TBL] [Abstract][Full Text] [Related]
6. Irinotecan in small-cell lung cancer: the US experience.
Sandler AB
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):11-2. PubMed ID: 11221015
[TBL] [Abstract][Full Text] [Related]
7. Current status of irinotecan in lung cancer.
Fukuoka M
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):6-7. PubMed ID: 11221022
[TBL] [Abstract][Full Text] [Related]
8. The emerging world role of irinotecan in lung cancer.
Langer CJ
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):15-21. PubMed ID: 11497227
[TBL] [Abstract][Full Text] [Related]
9. [Is small cell lung cancer an orphan disease?].
Pujol JL
Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S22-4. PubMed ID: 16719152
[No Abstract] [Full Text] [Related]
10. Irinotecan: summary and future directions.
Johnson DH
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):46-7. PubMed ID: 11221021
[No Abstract] [Full Text] [Related]
11. Topoisomerase I inhibitors in small-cell lung cancer. The Japanese experience.
Saijo N; Horiike A
Oncology (Williston Park); 2004 Jun; 18(7 Suppl 4):11-6. PubMed ID: 15255163
[TBL] [Abstract][Full Text] [Related]
12. [Irinotecan in the treatment of stomach cancer].
Barone C
Tumori; 2001; 87(6):A33-5. PubMed ID: 11995706
[No Abstract] [Full Text] [Related]
13. Role of topoisomerase I inhibitors in small-cell lung cancer.
Fukuoka M
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):9-13. PubMed ID: 11497234
[TBL] [Abstract][Full Text] [Related]
14. Irinotecan in small-cell lung cancer.
Ando Y; Figg WD
N Engl J Med; 2002 May; 346(18):1414-5; author reply 1414-5. PubMed ID: 11986422
[No Abstract] [Full Text] [Related]
15. [Irinotecan (CPT-11) therapy for advanced gastric cancer].
Sakata Y
Nihon Rinsho; 2001 Apr; 59 Suppl 4():386-92. PubMed ID: 11424411
[No Abstract] [Full Text] [Related]
16. Camptosar plus cisplatin increase survival in small-cell lung cancer study.
Oncology (Williston Park); 2000 Sep; 14(9):1294. PubMed ID: 11033827
[No Abstract] [Full Text] [Related]
17. Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer.
Lara PN; Gandara DR; Natale RB
Clin Lung Cancer; 2006 Mar; 7(5):353-6. PubMed ID: 16640809
[No Abstract] [Full Text] [Related]
18. Topoisomerase I targeting agents in small-cell lung cancer.
Ohe Y; Saijo N
Curr Oncol Rep; 2001 Mar; 3(2):170-8. PubMed ID: 11177750
[TBL] [Abstract][Full Text] [Related]
19. [Irinotecan hydrochloride (CPT-11) for advanced cervical cancer].
Terauchi F
Nihon Rinsho; 2004 Oct; 62 Suppl 10():175-8. PubMed ID: 15535228
[No Abstract] [Full Text] [Related]
20. Irinotecan for the treatment of cervical cancer.
Verschraegen CF
Oncology (Williston Park); 2002 May; 16(5 Suppl 5):32-4. PubMed ID: 12109804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
